News About: Pharm. Industry
Concerns growing over government's stern measures
Concerns have mounted following the government's unilateral administrative measure to cancel the title of innovative pharmaceutical firms that have been caught providing illicit kickbacks or rebate to hospitals, which...
Wholesalers, drugmakers to find ways for co-existence
Drug wholesalers is facing a strong backlash in its attempt to restrict the business scope of online drug shopping malls operated by Daewoong Pharm and Hanmi Pharm, as leading pharmaceutical companies are stepping up ...
Listed pharmaceutical firms to cut dividend payouts on uncertainties
Korea’ listed drug firms are likely to sharply reduce their cash dividends paid out to their shareholders this year as the government’s forced price cuts for drugs and growing economic uncertainties have led them to s...
Green Cross to supply flu vaccine for $12 million
Green Cross Corp., a Korean drug maker, said Monday it has won the order placed by the Pan American Health Organization (PAHO), a regional WHO body, to supply its influenza vaccines, worth $12 million, to South Americ...
Competition to heat up in domestic anti-hepatitis B drug market
Heated competition in the domestic anti-hepatitis B drug market, which has been dominated by BMS Korea’s Baraclude, is expected from next year because Yuhan Corp. and Boryung Pharm have been deploying aggressive marke...
Warning issued over Pradaxa
The Korea Food and Drug Administration said last Friday that individuals with prosthetic heart valves should not use Pradaxa, after data from a recently stopped clinical trial revealed that the newer blood thinner may...
Wholesalers get tougher on online drug shopping malls
The Korea Pharmaceutical Wholesaler Association (KPWA) has recently demanded that online drug shopping malls operated by Daewoong Pharm and Hanmi Pharm maintain the same drug pricing as the one adopted by drug wholesa...
Dong-A signs out-licensing agreement for novel DPP-IV inhibitor with Alkem India
Dong-A Pharm announced Friday that it has signed an out-licensing agreement for Dong-A’s novel and selective DPP-IV (dipeptidyl peptidase) inhibitor, DA-1229, with Alkem Laboratories, one of the largest pharmaceutical...
Government to back Huons’ sepsis drug development
Huons said Friday it plans to carry out Phase 1 clinical trial for its sepsis drug candidate in Korea as part of a government program to cultivate blockbuster drugs, targeting the international market.
The governm...
Zuellig Phama Korea to help Korean products gain in Asia
Zuellig Phama Korea (ZPK) has unveiled its plan to support Korean drug companies’ advancement into the Asian markets.
In a press interview on Thursday, ZPK’s president Christophe Piganiol said that the firm will h...
